Focus: Q-Linea is a Swedish biotech company specializing in blood analysis devices, operating as a public company since 2008. The company focuses on diagnostic instrumentation for clinical microbiology and infectious disease detection.
Profile data last refreshed 21h ago · AI intelligence enriched 2w ago
Stable — net +1 jobs in 30d
1 added, 0 removed. Backfill posture.
Early-career professionals should approach cautiously due to hiring freeze and unclear financial/operational status; best suited for diagnostics specialists with tolerance for small-cap volatility.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Q-Linea
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Q-Linea's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
q-linea ASTar clearance FDA - Infectious Disease Special Edition
q-linea ASTar clearance FDA Infectious Disease Special Edition
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles
Recent peer-reviewed publications with author affiliations at this company
Showing 5 of 6 publications